Article Versions Notes

Šíma M, Bobek D, Cihlářová P, Ryšánek P, Roušarová J, Beroušek J, Kuchař M, Vymazal T, Slanař O. Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin. Pharmaceutics. 2022; 14(8):1627. https://doi.org/10.3390/pharmaceutics14081627

Šíma, Martin, Daniel Bobek, Petra Cihlářová, Pavel Ryšánek, Jaroslava Roušarová, Jan Beroušek, Martin Kuchař, Tomáš Vymazal, and Ondřej Slanař. 2022. "Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin" Pharmaceutics 14, no. 8: 1627. https://doi.org/10.3390/pharmaceutics14081627

Šíma, M., Bobek, D., Cihlářová, P., Ryšánek, P., Roušarová, J., Beroušek, J., Kuchař, M., Vymazal, T., & Slanař, O. (2022). Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin. Pharmaceutics, 14(8), 1627. https://doi.org/10.3390/pharmaceutics14081627